Chemours (CC) Research & Development (2014 - 2026)

Chemours has reported Research & Development for 13 years, with the latest figure at $27.0 million in Q2 2026.

• On a quarterly basis, Research & Development fell 3.57% year-over-year to $27.0 million in Q2 2026; TTM through Jun 2026 was $106.0 million, a 3.64% decrease from a year earlier, with the FY2025 full-year figure at $108.0 million, down 0.92% from the prior year.
• Research & Development was $27.0 million for Q2 2026 at Chemours, up from $26.0 million in the prior quarter.
• The five-year high for Research & Development was $32.0 million in Q3 2022, with the low at $25.0 million in Q2 2022.
• Average Research & Development over 5 years is $27.5 million, with a median of $27.0 million recorded in 2025.
• The sharpest annual moves came in 2022 and 2023: Research & Development gained 25.0% in 2022, then slipped 13.33% in 2023.
• Over 5 years, Research & Development stood at $30.0 million in 2022, then retreated by 13.33% to $26.0 million in 2023, then changed by 0.0% to $26.0 million in 2024, then grew by 3.85% to $27.0 million in 2025, then changed by 0.0% to $27.0 million in 2026.
• The last three Research & Development figures came in at $27.0 million (Q2 2026), $26.0 million (Q1 2026), and $27.0 million (Q4 2025), per Business Quant data.